4DX Stock Overview
4DMedical Limited operates as a medical technology company in Australia and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
4DMedical Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.61 |
| 52 Week High | AU$1.27 |
| 52 Week Low | AU$0.45 |
| Beta | 1.29 |
| 1 Month Change | -6.15% |
| 3 Month Change | -1.61% |
| 1 Year Change | -26.06% |
| 3 Year Change | -62.35% |
| 5 Year Change | n/a |
| Change since IPO | -61.64% |
Recent News & Updates
Recent updates
4DMedical Limited's (ASX:4DX) CEO Compensation Is Looking A Bit Stretched At The Moment
Oct 26
Here's Why We're Not At All Concerned With 4DMedical's (ASX:4DX) Cash Burn Situation
Jun 16We Think 4DMedical (ASX:4DX) Needs To Drive Business Growth Carefully
Feb 01Is 4DMedical (ASX:4DX) In A Good Position To Deliver On Growth Plans?
Oct 18We're Hopeful That 4DMedical (ASX:4DX) Will Use Its Cash Wisely
Jul 05We Think 4DMedical (ASX:4DX) Can Afford To Drive Business Growth
Jan 27Here's Why We're Not Too Worried About 4DMedical's (ASX:4DX) Cash Burn Situation
Jun 05Is 4DMedical Limited's (ASX:4DX) Shareholder Ownership Skewed Towards Insiders?
Feb 20
Shareholder Returns
| 4DX | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | 3.4% | -5.1% | -2.2% |
| 1Y | -26.1% | 52.0% | 4.5% |
Return vs Industry: 4DX underperformed the Australian Healthcare Services industry which returned 52% over the past year.
Return vs Market: 4DX underperformed the Australian Market which returned 4.5% over the past year.
Price Volatility
| 4DX volatility | |
|---|---|
| 4DX Average Weekly Movement | 8.2% |
| Healthcare Services Industry Average Movement | 8.2% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in AU Market | 17.6% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: 4DX's share price has been volatile over the past 3 months.
Volatility Over Time: 4DX's weekly volatility has decreased from 15% to 8% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 131 | Andreas Fouras | 4dmedical.com |
4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lungs ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator.
4DMedical Limited Fundamentals Summary
| 4DX fundamental statistics | |
|---|---|
| Market cap | AU$234.82m |
| Earnings (TTM) | -AU$30.83m |
| Revenue (TTM) | AU$1.03m |
232.9x
P/S Ratio-7.7x
P/E RatioIs 4DX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4DX income statement (TTM) | |
|---|---|
| Revenue | AU$1.03m |
| Cost of Revenue | AU$51.29k |
| Gross Profit | AU$973.93k |
| Other Expenses | AU$31.81m |
| Earnings | -AU$30.83m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.079 |
| Gross Margin | 95.00% |
| Net Profit Margin | -3,007.65% |
| Debt/Equity Ratio | 0% |
How did 4DX perform over the long term?
See historical performance and comparison